Introduction
============

Plants mainly rely on two conceptual layers of immune systems to prevent infection and disease. The first system, PTI (PAMP-triggered immunity), involves the detection of PAMPs (pathogen-associated molecular patterns) through PRRs (pattern-recognition receptors). The second layer, ETI (effector-triggered immunity), specifically recognizes effector proteins that pathogens secrete to suppress PTI and achieve virulence. ETI involves the detection of effectors through R (resistance) proteins that can induce a rapid and robust immune response ([@B33]; [@B5]).

Although plant immune receptors can confer resistance, their over-accumulation or constitutive activity can impair plant growth and development and result in autoimmune phenotypes in the absence of pathogens ([@B69]). For example, *snc1-1 (suppressor of npr1-1, constitutive 1)*, a gain-of-function mutant in an immune receptor-coding gene, exhibits constitutive defense activation without pathogen attack, resulting in autoimmune phenotypes which include dwarf stature, increased SNC1 protein stability, high defense marker gene expression, elevated defense hormone SA (salicylic acid) accumulation and disease resistance ([@B78]; [@B10]). Therefore, in order to balance appropriate plant immune signaling with normal growth and development, the transient levels of immune receptors in the cell must be tightly controlled. However, the molecular mechanisms that regulate the abundance of receptor proteins are still unclear ([@B38]).

In eukaryotes, PTMs (protein post-translational modifications), such as sumoylation, phosphorylation, acetylation, and ubiquitination, can result in the generation or adjustment of important molecular signals. There are several examples in plant immunity where these modifications have been reported to participate in the regulation of plant disease-resistant immune signals ([@B10]; [@B30]; [@B14]; [@B42]; [@B57]; [@B74]; [@B79]; [@B11]; [@B22]). In these modalities, ubiquitination is considered a hub for the regulation of plant immune signals ([@B9]).

The ubiquitination process is an ATP-dependent conjugation cascade involving a series of enzymes, including an ubiquitin activating enzyme E1, an ubiquitin conjugating enzyme E2, and an ubiquitin ligase E3. Usually, an E1 activates Ub (ubiquitin) and transfers it to an E2. An E3 connects a substrate that it specifically recognizes to the Ub molecule conjugated by the E2 ([@B56]; [@B44]). In addition, there is an ubiquitin elongating enzyme E4 that contributes to poly-ubiquitination ([@B40]; [@B30]; [@B16]).

In the process of ubiquitination, the immune proteins are specifically recognized by ubiquitin ligase E3s. However, a number of studies have found that the specific recognition of immune proteins is not solely determined by the corresponding ubiquitin ligase E3s, and can require further substrate modifications ([@B60]; [@B41]; [@B74]). The homeostatic regulation of immune protein is more sophisticated and complex than current models suggest. Upstream of ubiquitination, a variety of protein post-translational modifications, serve as degrons for ubiquitination and ubiquitin-dependent degradation ([@B76]; [@B52]; [@B74]). In this review, we summarize recent advances in the regulation of plant immune protein turnover, and propose an updated model on the control pathways of immune receptors through sumoylation, phosphorylation, acetylation, and ubiquitination.

Sumoylation
===========

Sumoylation is a PTM that involves the attachment of SUMO (small-ubiquitin-like modifier) proteins to specific lysine residues on substrates. The process by which SUMO chains form and the three-dimensional structure of SUMO proteins is similar to ubiquitination. However, sumoylation seems to be involved in different biological processes compared to ubiquitination, such as genome stability, protein sorting and activation, signal transduction, cell cycle, etc. ([@B1]; [@B47]; [@B53]; [@B72]). The functional study of SUMO proteins in plants began in 1999 when a novel tomato SUMO protein, with homology to human SUMO1, was found to inhibit EIX-induced (ethylene-inducing xylanase) cell death ([@B25]). With the discovery and characterization of two SUMO E3 coding genes *SIZI* (*SAP* and *MIZ1*) and *MMS21*/*HPY2* (*Methyl Methanesulfonate-sensitivity Protein 21*/*High Ploidy 2*) in *Arabidopsis thaliana*, as well two SUMO E4 coding genes *PIAL1* and *PIAL2* (*Protein Inhibitor of Activated STAT Like1/2*), the roles of sumoylation in regulating plant processes are emerging ([@B46]; [@B28]; [@B32]; [@B65]; [@B36]). In plant immunity, SUMO modification seems to play both positive and negative regulatory roles ([@B37]; [@B68]; [@B3]; [@B8]).

Current models suggest that there are three main relationships between sumoylation and ubiquitination: antagonism, synergism or feedback, and degron mediation. Firstly, sumoylation and ubiquitination can antagonistically compete for the same lysine residue of target substrates ([@B27]; [@B66]). In some cases antagonistic effects can also be observed between sumoylation and ubiquitination when the modification site is not the same ([@B12]; [@B20]). Secondly, ubiquitination and sumoylation can affect one another positively in a feedback loop. For example, SUMO E3 SIZ1 can enhance the transubiquitination activity of COP1 (constitutive photomorphogenic 1), an ubiquitin E3 ligase, but its own protein level and stability is modulated by COP1 ([@B39]). Thirdly, sumoylation can function as a degron mediating ubiquitin-dependent degradation by the proteasome ([@B45]; [@B43]; [@B52]). STUbLs (SUMO-targeted ubiquitin ligases), identified in yeast, humans and plants, regulate the level and stability of sumoylated proteins and act downstream of sumoylation ([@B73]; [@B64]; [@B15]).

In plant immunity, there are two immunity-related studies supporting that sumoylated residues act as degrons for ubiquitous degradation in plants. Firstly, SIZ1 was found to contribute to the turnover of SNC1 and play a role in plant immunity. The loss-of-function mutant of *SIZ1* exhibited autoimmune phenotypes that are partly dependent on SNC1, and over-expression of CPR1 (constitutive expressor of PR genes 1), an E3 ubiquitin ligase previously reported to target SNC1 for degradation, could restore the growth defects caused by *siz1* ([@B23], [@B22]). SIMs (SUMO-interaction motifs) are sequences that can mediate the binding of proteins to sumoylated substrates. For example, sumoylated PCNA (proliferating-cell nuclear antigen) can be recognized by the SIM of the ubiquitin ligase Rad18 (radiation-sensitive 18) in yeast ([@B51]). In SNC1, there are four sumoylation sites and five putative SIMs ([@B22]). It would be interesting to determine whether sumoylation enhances SNC1 turnover, increasing its ubiquitination and proteasome-mediated degradation.

A second example involves the key SA receptor and transcriptional activator, NPR1 (non-expressor of PR genes 1). Under normal conditions, NPR1 mainly exists in the cytoplasm as an oligomer, but a small amount of NPR1 monomer can be sumoylated, transported to the nucleus, and degraded through ubiquitination-mediate pathways. This process maintains NPR1-mediated basic immunity and restricts its co-activator activity to prevent autoimmunity. In the presence of pathogens, accumulation of SA triggers the reduction of NPR1 oligomers to monomers, the sumoylation of the monomers, and finally the translocation of the monomers into the nucleus to promote defense gene transcription. NPR1 contains a BTB/POZ (for Broad Complex, Tramtrack and Bric-a-brac/Pox Virus and Zinc Finger) domain, which functions as a substrate adapter of SCF (Skp1-cullin1-F-box) -type ubiquitin ligase E3s ([@B55]). Interestingly, BTB-type proteins themselves may also be substrates for SCF complexes ([@B6]). NPR1 can be phosphorylated at residues Ser11/Ser15 to facilitate further sumoylation of NPR1 and promote its recruitment to Cullin-based ubiquitin ligase E3 for degradation ([@B60]; [@B42]; [@B57]). It is likely that the ubiquitination of mission-capable NPR1 from the target gene promoter promotes NPR1 in the cytoplasm to translocate to the nucleus to launch a fresh transcription cycle.

Phosphorylation
===============

Phosphorylation refers to the addition of a phosphoric acid group to proteins or other functional molecules. Protein phosphorylation is a reversible reaction that occurs mainly on serine, threonine, and tyrosine residues. The main role of serine and threonine phosphorylation is to alter the protein activity state from inactive to active ([@B54]). Tyrosine phosphorylation, on the other hand, generally provides a structural group to facilitate interactions with other proteins, in order to form poly-protein complexes that further promote protein phosphorylation in a phosphorylation cascade ([@B35]). The signal generated is eventually transferred to the nucleus, leading to transcriptional changes ([@B17]). There is emerging evidence that phosphorylation plays a role upstream of ubiquitination in plant innate immunity ([@B41]; [@B57]; [@B62]).

*Arabidopsis* BIK1 (botrytis-induced kinase 1) is a cytosolic kinase that phosphorylates and enhances the activity of BAK1 (BRI1-associated receptor kinase 1). A yeast two-hybrid screen done using BAK1 as bait isolated PUB13 (plant U-box 13), an ubiquitin ligase E3, which possesses an N-terminal U-box domain. Further studies show that BAK1 phosphorylates PUB13 and its close homolog PUB12, and that this phosphorylation is required in order for the E3s to associate with and ubiquitinate FLS2 (flagellin sensitive 2), a plasma-membrane-localized PRR protein ([@B19]; [@B41]; [@B79]). In this example, the FLS2-mediated immune response is regulated by a phosphorylation cascade pathway, which determines which proteins to degrade via ubiquitination and which to maintain for sustained immune signaling.

Rice PRR protein Xa21 (*Xanthomonas oryzae* pv. Oryzae 21) has many auto-phosphorylated sites in the JM (juxtamembrane) domain, and can interact with a RING-type ubiquitin ligase XB3 (Xa21 binding protein 3), which maintains the stability of Xa21 ([@B71]; [@B75]). Recent studies found that Thr-705 in the JM domain of Xa21 is essential for its auto-phosphorylation and that mutation in Thr-705 abolished the interaction between Xa21 with XB3, suggesting that Thr-705 plays an important biological function in Xa21-mediated defense. Upon pathogen infection, Xa21 recognizes PAMPs and transfers phosphate groups to XB3, leading to XB3 self-ubiquitination and activation of MAPK (mitogen-activated protein kinase) cascades-mediated resistance ([@B7]; [@B50]; [@B29]).

Furthermore, there are more sophisticated phosphorylation mechanisms to regulate defense related proteins in multiple layers. EIN3 (ethylene-insensitive 3), is a plant-specific nuclear transcription factor that functions in MAPK cascades to initiate downstream transcriptional cascades for ethylene responses. EIN3 interacts with two F-box-type ubiquitin ligases, EBF1 (early B-cell factor 1) and EBF2 and is ubiquitinated and degraded by the 26S proteasome. There is a dual phosphorylation modulatory mechanism for EIN3 stability: MKK9 (MAP kinase kinase 9) phosphorylates T174 to promote EIN3 stability whereas CTR1 (copper transporter 1) phosphorylates T592 to facilitate EIN3 degradation ([@B4]; [@B76]; [@B63]). Similarly, the phosphorylation sites at Ser11/Ser15 of NPR1 promote its ubiquitin-mediated degradation; while the sites at Ser55/Ser59 maintain NPR1 stability and inactivity ([@B60]; [@B57]). It would be interesting to investigate whether the phosphorylation sites of Xa21 also have opposing functions.

Acetylation
===========

It has been well-established that histone acetylation plays a key role in DNA transcription, and that acetylation of non-histones plays an important role in cellular events ([@B59]; [@B24]). Recently, more studies have revealed that N-terminal (Nt) acetylation can serve as signals for ubiquitin-mediated protein degradation ([@B31]; [@B18]; [@B74]). Pathogen effectors can also acetylate immune receptors to promote infection ([@B58]).

Akin to the dual roles of phosphorylation in PTI, Nt-acetylation serves two functions in SNC1-mediated immunity ([@B74]). The Nt-acetylation of SNC1 was first identified in *muse6* (*mutant, snc1-enhancing 6*), a mutant derived from *mos4* (*modifier of snc1 4*) *snc1* background with strong autoimmunity phenotypes. Sequence homology analysis revealed that *Arabidopsis* MUSE6 is an ortholog of Yeast Naa15 \[N (alpha)-acetyltransferase 15\], the subsidiary subunit of NatA (N-terminal acetyltransferase complex A), suggesting that Nt-acetylation contributes to SNC1 degradation. Interestingly, SNC1 seemed to have distinct N-terminal isoforms as detected by MS analysis, which may have been generated through alternative initiation and Nt-acetylation. Affinity purification and *in vitro* enzymatic assays proved that its first Met is acetylated by NatA serving as a degron for ubiquitination, while the second Met is acetylated by NatB, stabilizing SNC1. The turnover of RPM1 was also linked with NatA, but not NatB ([@B67]; [@B14]; [@B74]). Interestingly, the antagonistic function of NatA and NatB is also observed in flowering time ([@B34]).

Many N-terminally acetylated amino acids which are targeted by NatA act as degrons in yeast and are recognized by the ubiquitin E3 Doa10 (degradation of Alpha2 10) for degradation ([@B31]; [@B77]). Thus, it is hypothesized that a single immune protein can be Nt-acetylated in different ways by different Nats, and the acetylation can be differentially recognized by different ubiquitin ligase E3s, providing regulation through two antagonistic downstream routes. However, it has not been confirmed whether acetylation changes the charge state or the spatial structure of SNC1 to expose its ubiquitin recognition site to be recognized by E3; or whether the ubiquitin ligase E3 directly recognizes the acetylated site. Therefore, unlike the diverse mechanisms of interaction between sumoylation and ubiquitination, the relationship between acetylation and ubiquitination or sumoylation remains to be explored in detail. Structural studies of the E3 recognition site will contribute a better understanding to the synergistic mechanisms of acetylation, ubiquitination, and sumoylation.

Ubiquitination
==============

Ubiquitination plays a significant role in regulating plant immunity. For example, ubiquitin ligase E3s prevent overproduction of immune proteins ([@B9]; [@B13]). One example is *Arabidopsis* ubiquitin ligase CPR1, an F-box protein that regulates the resistance pathways mediated by R proteins such as SNC1 and RPS2. The autoimmune phenotypes of *cpr1* are SNC1-dependent, and CPR1 can decrease SNC1 level via ubiquitin-mediated degradation ([@B10]; [@B21]).

Since poly-ubiquitination is the most suitable form of ubiquitination for protein degradation, and since the integrated activities of E1s, E2s, and E3s are rarely effective in adding more than three ubiquitin molecules to substrates, there must be a ubiquitin extension factor involved in the poly-ubiquitination of proteins which is named E4 ([@B48]; [@B49]). Yeast Ufd2 (ubiquitin fusion degradation protein 2), the first discovered and best characterized E4 factor, has a C-terminal U-box domain, which promotes the assembly of poly-ubiquitin chain cooperating with E1s, E2s, and E3s ([@B26]). Yeast Cdc48 (cell division cycle 48), a conserved ATPase among eukaryotes, interacts with Ufd2 and may play an important role in transporting ubiquitous targets to the proteasome ([@B2]).

At present, many Ufd2 orthologs have been functionally studied: the mouse E4B (also known as Ufd2a), the human GP78 (glycoprotein of Mr 7800) and MUSE3 from *Arabidopsis* ([@B61]; [@B30]; [@B70]). MUSE3, the only E4 factor in *Arabidopsis* identified from a forward genetic screen in the background of *mos4 snc1*, affects SNC1 and RPS2 protein levels and relies on CPR1 through the UPS (ubiquitin proteasome system) pathway. Co-IP experiments revealed that MUSE3 appears to directly interact with SNC1, but not with RPS2, indicating that the association between MUSE3 and RPS2 may need an unknown intermediary agent ([@B30]). There is also an ATPase MUSE8 that interacts with MUSE3 to negatively regulate plant immunity ([@B11]).

At present, it is hypothesized that E4s functions in E3-E4 or E4-substrate complexes to assist the transfer of ubiquitin molecules from E2s to the targets, or to add ubiquitin molecules to the targets after E3s' function ([@B30]; [@B16]). There are more than 1000 genes coding ubiquitin ligase E3s in the *Arabidopsis* genome, with the biological function of most genes uncharacterized. Therefore, further investigation will be necessary to identify other E3s, E4s and their targets, thus to understand the homeostatic regulatory mechanism of immune proteins.

Conclusion and Perspectives
===========================

Over the past 10 years, ubiquitination has emerged to be a vital regulatory mechanism in plant biology that is controlled at multiple levels, even in a single signal response pathway. Moreover, ubiquitin molecules can complete the correct assembly and folding of some proteins through the combination of E1s, E2s, and E3s and participate in the regulation of some protein activity. Therefore, the destruction, modification, or recombination of components in UPS can directly or indirectly affect plant hormonal signaling pathways, gene transcription, morphogenesis, resistance to harsh environments, and competition between plants and pathogens. Although recent research has provided us with a basic understanding of the function of UPS pathways in plant immunity, the biochemical mechanisms and physiological functions of ubiquitination are far from being fully understood.

The existence of a variety of PTMs that work together with ubiquitination is thought to provide flexibility for regulation of target protein involved in plant immunity under dynamic cellular conditions (**Figure [1](#F1){ref-type="fig"}**). Similar mechanisms may be particularly important during growth and development, stress responses, flowering, etc. to ensure an appropriate concentration of regulatory proteins is reached in a timely manner.

![Model on how ubiquitination reacts with sumoylation, phosphorylation, and acetylation to fine-tune the turnover of plant immune components. **(A)** Under normal conditions, sumoylated positive regulators further go through phosphorylation or acetylation on the site1 (e.g., NPR1: Ser11/15 and SNC1: Met1, respectively), which serves as degron, leading to protein degradation through the UPS. Or protein sumoylation alone (e.g., SNC1: Lys129/271/588/1048) may promote its degradation through the UPS. **(B)** Under abnormal conditions, positive regulators or sumoylated positive regulators go through phosphorylation or acetylation on the site2 (e.g., NPR1: Ser55/59 and SNC1: Met2, respectively), which prevents protein degradation through the UPS, leading to protein accumulation. In the model, dash arrows stand for uncertain events.](fpls-08-01682-g001){#F1}

There are still many problems that remain unsolved. One of the biggest challenges is to identify the targets of the E3s that participate in plant immunity. Furthermore, how do E3s identify their substrates? What are the characteristics of these substrates? How is the activity of ubiquitous enzymes itself regulated? What is the relationship between different E3s and E4s? Finally, how are ubiquitination and other PTMs such as sumoylation, phosphorylation, and acetylation related? The questions above remained to be resolved through in-depth cooperative and multi-disciplinary studies on plant immunity. Approaches, such as targeted reverse genetics as well as carefully designed novel forward genetic screens and global protein stability profiling, will enable us to reveal these mysteries.

Future research in this area can uncover the intricate interactions among different PTMs, but can also increase the understanding of the function of the UPS. Moreover, exploring the mechanism of plant defense against pathogen infection through the immune system could lead to ideas that eventually become varities of disease resistance that could be implemented in economically important crops.
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